Zynex ROE 2006-2019 | ZYXI

Current and historical return on equity (ROE) values for Zynex (ZYXI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zynex ROE for the three months ending June 30, 2019 was 88.15%.
Zynex ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.01B $0.01B 90.91%
2019-03-31 $0.01B $0.01B 105.26%
2018-12-31 $0.01B $0.01B 129.03%
2018-09-30 $0.01B $0.01B 148.15%
2018-06-30 $0.01B $0.01B 180.00%
2018-03-31 $0.01B $0.01B 360.00%
2017-12-31 $0.01B $0.01B 1400.00%
2017-09-30 $0.00B $0.00B -228.57%
2017-06-30 $0.00B $-0.00B -92.31%
2017-03-31 $0.00B $-0.00B -25.00%
2016-12-31 $0.00B $-0.00B -23.53%
2016-09-30 $0.00B $-0.00B 0.00%
2016-06-30 $-0.00B $-0.01B 25.00%
2016-03-31 $-0.00B $-0.00B 28.57%
2015-12-31 $-0.00B $-0.00B 66.67%
2015-09-30 $0.00B $-0.00B 0.00%
2015-06-30 $0.00B $-0.00B 0.00%
2015-03-31 $-0.01B $-0.00B 342.86%
2014-12-31 $-0.01B $-0.00B 1200.00%
2014-09-30 $-0.01B $-0.00B -1200.00%
2014-06-30 $-0.01B $-0.00B -346.67%
2014-03-31 $-0.01B $0.00B -133.33%
2013-12-31 $-0.01B $0.01B -88.89%
2013-09-30 $-0.00B $0.01B -27.91%
2013-06-30 $-0.00B $0.01B -17.39%
2013-03-31 $0.00B $0.01B 0.00%
2012-12-31 $0.00B $0.01B 0.00%
2012-09-30 $0.00B $0.01B 9.09%
2012-06-30 $0.00B $0.01B 19.51%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 22.22%
2011-09-30 $0.00B $0.01B 11.76%
2011-06-30 $0.00B $0.01B 0.00%
2011-03-31 $0.00B $0.01B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-09-30 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2010-03-31 $0.00B $0.01B 14.81%
2009-12-31 $0.00B $0.01B 32.00%
2009-09-30 $0.00B $0.01B 34.78%
2009-06-30 $0.00B $0.01B 33.33%
2009-03-31 $0.00B $0.01B 16.00%
2008-12-31 $0.00B $0.01B 0.00%
2008-09-30 $0.00B $0.01B 16.67%
2008-06-30 $0.00B $0.01B 42.11%
2008-03-31 $0.00B $0.01B 57.14%
2007-12-31 $0.00B $0.00B 72.73%
2007-09-30 $0.00B $0.00B 50.00%
2007-06-30 $0.00B $0.00B 0.00%
2007-03-31 $0.00B $0.00B 0.00%
2006-12-31 $0.00B $0.00B 0.00%
2006-09-30 $0.00B $0.00B 0.00%
2006-06-30 $0.00B $0.00B 0.00%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.319B $0.032B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.355B 27.89
Medtronic (MDT) Ireland $136.463B 19.49
Stryker (SYK) United States $80.545B 27.85
Boston Scientific (BSX) United States $58.324B 28.29
Baxter (BAX) United States $43.795B 26.56
EssilorLuxottica Societe Anonyme (ESLOY) France $30.720B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.744B 17.76
Coloplast (CLPBY) Denmark $26.309B 42.00
Lonza Group Ag (LZAGY) Switzerland $25.750B 0.00
Terumo (TRUMY) Japan $23.727B 27.28
Smith & Nephew SNATS (SNN) United Kingdom $19.987B 0.00
ResMed (RMD) United States $19.012B 36.26
Sunny Optical Technology (SNPTF) China $13.031B 0.00
Bio-Rad Laboratories (BIO) United States $9.510B 50.98
Canopy Growth (CGC) Canada $9.478B 0.00
Insulet (PODD) United States $9.126B 540.75
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.016B 20.92
Haemonetics (HAE) United States $6.910B 52.15
Perrigo (PRGO) Ireland $6.214B 11.45
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
Aurora Cannabis (ACB) Canada $5.769B 56.70
GW Pharmaceuticals (GWPH) United Kingdom $4.612B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.587B 59.66
ICU Medical (ICUI) United States $3.452B 22.39
NuVasive (NUVA) United States $3.286B 26.19
Hutchison China MediTech (HCM) China $2.661B 0.00
Quidel (QDEL) United States $2.508B 24.91
Agios Pharmaceuticals (AGIO) United States $2.497B 0.00
National Vision Holdings (EYE) United States $2.260B 48.78
Cardiovascular Systems (CSII) United States $1.637B 0.00
Aphria (APHA) $1.496B 0.00
Phibro Animal Health (PAHC) United States $1.215B 18.20
AtriCure (ATRC) United States $1.045B 0.00
VAREX IMAGING (VREX) United States $0.981B 22.60
NanoString Technologies (NSTG) United States $0.942B 0.00
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.862B 20.36
Lantheus Holdings (LNTH) United States $0.850B 22.34
Eagle Pharmaceuticals (EGRX) United States $0.772B 19.67
Cerus (CERS) United States $0.731B 0.00
MacroGenics (MGNX) United States $0.708B 0.00
Quanterix (QTRX) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.621B 0.00
LeMaitre Vascular (LMAT) United States $0.615B 36.47
Surmodics (SRDX) United States $0.597B 113.41
OraSure Technologies (OSUR) United States $0.441B 20.40
Meridian Bioscience (VIVO) United States $0.427B 13.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.413B 0.00
BioLife Solutions (BLFS) United States $0.361B 118.69
United Health Products (UEEC) United States $0.357B 0.00
Utah Medical Products (UTMD) United States $0.356B 26.05
Owens & Minor (OMI) United States $0.304B 9.11
Vapotherm (VAPO) United States $0.251B 0.00
Bovie Medical (APYX) United States $0.248B 0.00
Chimerix (CMRX) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Fonar (FONR) United States $0.151B 7.97
Female Health (VERU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 20.55
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.054B 0.00
Trinity Biotech (TRIB) Ireland $0.045B 15.58
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00